General MedicationsORALGeneric
EPROSARTAN MESYLATE
EPROSARTAN MESYLATE
Standard Dose
EQ 400MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview EPROSARTAN MESYLATE is listed in Drugs@FDA under application 202012 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient EPROSARTAN MESYLATE Form and strength TABLET;ORAL - EQ 400MG BASE Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2015-11-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview EPROSARTAN MESYLATE is listed in Drugs@FDA under application 202012 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient EPROSARTAN MESYLATE Form and strength TABLET;ORAL - EQ 400MG BASE Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2015-11-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.